共有 1 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R026765-100mg | 100mg | 5~7个工作日 |
Vc-MMAD Vc-MMAD |
99% |
|
|
| 罗恩 | R026765-10mg | 10mg | 5~7个工作日 |
Vc-MMAD Vc-MMAD |
99% |
|
|
| 罗恩 | R026765-25mg | 25mg | 5~7个工作日 |
Vc-MMAD Vc-MMAD |
99% |
|
|
| 罗恩 | R026765-50mg | 50mg | 5~7个工作日 |
Vc-MMAD Vc-MMAD |
99% |
|
|
| 罗恩 | R026765-5mg | 5mg | 5~7个工作日 |
Vc-MMAD Vc-MMAD |
99% |
|
|
| 阿拉丁 | V125316-5mg | 5mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 阿拉丁 | V125316-10mg | 10mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 阿拉丁 | V125316-25mg | 25mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 阿拉丁 | V125316-50mg | 50mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 阿拉丁 | V125316-100mg | 100mg | 期货,请咨询 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 阿拉丁 | V125316-1mg | 1mg | 期货,请咨询 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 毕得 | BD630225-5mg | 5mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98% |
|
|
| 毕得 | BD630225-10mg | 10mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98% |
|
|
| 毕得 | BD630225-25mg | 25mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98% |
|
|
| 毕得 | BD630225-50mg | 50mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98% |
|
|
| 毕得 | BD630225-100mg | 100mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98% |
|
|
| solarbio | IQP00168-1mg | 1mg | 请咨询 | Vc-MMAD |
|
|
|
| solarbio | IQP00168-5mg | 5mg | 请咨询 | Vc-MMAD |
|
|
|
| solarbio | IQP00168-10mg | 10mg | 请咨询 | Vc-MMAD |
|
|
|
| 源叶 | S83122-5mg | 5mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 源叶 | S83122-10mg | 10mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 源叶 | S83122-25mg | 25mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 源叶 | S83122-50mg | 50mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| 源叶 | S83122-100mg | 100mg | 现货 |
Vc-MMAD,用于偶联抗体 Vc-MMAD |
≥97% |
|
|
| Target Mol | T18870-25mg | 25 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Target Mol | T18870-50mg | 50 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Target Mol | T18870-10mg | 10 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Target Mol | T18870-1mg | 1 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Target Mol | T18870-100mg | 100 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Target Mol | T18870-5mg | 5 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Target Mol | T18870-200mg | 200 mg | 现货 |
化合物Vc-MMAD Vc-MMAD |
98.33% |
|
|
| Am | A371033-5mg | 5mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98 |
|
|
| Am | A371033-50mg | 50mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98 |
|
|
| Am | A371033-25mg | 25mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98 |
|
|
| Am | A371033-10mg | 10mg | 现货 |
4-((S)-2-((S)-2-(6-(2,5-二氧代-... Vc-MMAD |
98 |
|
|
| MCE | HY-15742-50mg | 50mg | 现货 |
Vc-MMAD Vc-MMAD |
99.96% |
|
|
| MCE | HY-15742-25mg | 25mg | 现货 |
Vc-MMAD Vc-MMAD |
99.96% |
|
|
| MCE | HY-15742-10mg | 10mg | 现货 |
Vc-MMAD Vc-MMAD |
99.96% |
|
|
| MCE | HY-15742-5mg | 5mg | 现货 |
Vc-MMAD Vc-MMAD |
99.96% |
|
|
| MCE | HY-15742-1mg | 1mg | 现货 |
Vc-MMAD Vc-MMAD |
99.96% |
|
|